ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Pacira BioSciences, Inc. Traders to Safe Counsel Earlier than Essential Deadline in Securities Class Motion – PCRX By Investing.com
New York, New York--(Newsfile Corp. - January 23, 2025) - WHY: Rosen…
Anixa Biosciences CEO Amit Kumar buys $95,890 in widespread inventory By Investing.com
This acquisition displays Kumar's continued funding in Anixa Biosciences (NASDAQ:), an organization…
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Caribou Biosciences, Inc. Buyers to Safe Counsel Earlier than Vital Deadline in Securities Class Motion – CRBU By Investing.com
New York, New York--(Newsfile Corp. - January 11, 2025) - WHY: Rosen…
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC improvement By Investing.com
Samsung (KS:) Biologics to supply ADC providers at new devoted facilityProlonged collaboration…
Arcus Biosciences Proclaims New Employment Inducement Grants By Investing.com
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, international biopharmaceutical firm targeted…
Ventyx Biosciences’ chief scientific officer sells $29,682 in inventory By Investing.com
John Nuss, the Chief Scientific Officer of Ventyx Biosciences, Inc. (NASDAQ:VTYX), not…
Aura Biosciences CEO Elisabet de los Pinos sells $98,787 in inventory By Investing.com
BOSTON—Elisabet de los Pinos, President and CEO of Aura Biosciences, Inc. (NASDAQ:AURA),…
IDEAYA Biosciences Proclaims IND-Clearance for Werner Helicase Improvement Candidate IDE275 (GSK959) for a Part 1 Examine in MSI-Excessive Stable Tumors By Investing.com
IDE275 (GSK959) growth is progressing into First-in-Human Part 1 scientific trial(s) for…
Precision BioSciences to Take part in Upcoming Longwood Boston CEO and Guggenheim Healthcare Conferences By Investing.com
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a medical stage gene enhancing…
Avidity Biosciences CEO sells over $1.4 million in firm inventory By Investing.com
In a latest transaction, Sarah Boyce, the President and CEO of Avidity…
